6,282
Views
35
CrossRef citations to date
0
Altmetric
Perspective

Microfluidic On-Chip Biomimicry for 3D Cell Culture: a Fit-For-Purpose Investigation From the End User Standpoint

, &
Article: FSO173 | Received 16 Nov 2016, Accepted 19 Jan 2017, Published online: 02 Mar 2017

Figures & data

Figure 1. Preclinical and clinical models for drug development.

With an increase in system complexity, preclinical models range from 2D petri dish, to 3D in vitro and ex vivo culture systems, to in vivo animal models. Clinical studies are based on human subjects and consist of four testing phases.

CAM: Chicken chorioallantoic membrane assay.

Figure 1.  Preclinical and clinical models for drug development.With an increase in system complexity, preclinical models range from 2D petri dish, to 3D in vitro and ex vivo culture systems, to in vivo animal models. Clinical studies are based on human subjects and consist of four testing phases.CAM: Chicken chorioallantoic membrane assay.

Figure 2. Key microenvironment homeostasis and spatiotemporal dynamics that are desirable to be modeled in in vitro 3D culture systems.

All microenvironment cues are dynamic, heterotypic and drivers of cell behavior and fate.

ECM: extracellular matrix; GF: growth factor.

Adapted from [Citation82,Citation83].

Figure 2.  Key microenvironment homeostasis and spatiotemporal dynamics that are desirable to be modeled in in vitro 3D culture systems.All microenvironment cues are dynamic, heterotypic and drivers of cell behavior and fate.ECM: extracellular matrix; GF: growth factor.Adapted from [Citation82,Citation83].

Figure 3. Characterization of research area, usage and acceptability of microfluidic culture systems, usage of analytical tools and concerns about new culture technology among biomedical researchers.

(A) The cohort consists of scientists from fundamental, interdisciplinary research and drug discovery industry. (B) Few researchers have previous experience of using complex 3D culture models including microfluidics. (C) Acceptance of 3D culture systems including microfluidics is a predominant response. (D) Popular analytical tools for biomedical scientists include western blotting, PCR, immunofluorescence microscopy, live cell imaging, flow cytometry and ELISA. (E) Potential users are concerned about the reproducibility, standardization, validation, user-friendliness and compatibility of new culture technology.

PCR: Polymerase chain reaction.

Figure 3.  Characterization of research area, usage and acceptability of microfluidic culture systems, usage of analytical tools and concerns about new culture technology among biomedical researchers.(A) The cohort consists of scientists from fundamental, interdisciplinary research and drug discovery industry. (B) Few researchers have previous experience of using complex 3D culture models including microfluidics. (C) Acceptance of 3D culture systems including microfluidics is a predominant response. (D) Popular analytical tools for biomedical scientists include western blotting, PCR, immunofluorescence microscopy, live cell imaging, flow cytometry and ELISA. (E) Potential users are concerned about the reproducibility, standardization, validation, user-friendliness and compatibility of new culture technology.PCR: Polymerase chain reaction.

Figure 4. coculture number, extracellular matrix, product type and price expected by researchers.

(A) ACR prefer complex 3D culture systems enabling the coculture of more than four types of cells. ECR require two or three cell types in coculture. (B) ACR prefer 3D scaffold/hydrogel and endogenous ECM. ECR prefer thin coating of ECM molecules and 3D scaffold/hydrogel. (C) ACR prefer more customized culture systems. ECR require standardized products. (D) ACR are willing to pay double or even triple price for 3D culture models. ECR will pay less.

ACR: Advanced-career researcher; ECM: Extracellular matrix; ECR: Early-career researcher.

Figure 4.  coculture number, extracellular matrix, product type and price expected by researchers.(A) ACR prefer complex 3D culture systems enabling the coculture of more than four types of cells. ECR require two or three cell types in coculture. (B) ACR prefer 3D scaffold/hydrogel and endogenous ECM. ECR prefer thin coating of ECM molecules and 3D scaffold/hydrogel. (C) ACR prefer more customized culture systems. ECR require standardized products. (D) ACR are willing to pay double or even triple price for 3D culture models. ECR will pay less.ACR: Advanced-career researcher; ECM: Extracellular matrix; ECR: Early-career researcher.

Table 1. Functions of microenvironment cues and biomimetic examples in various 3D culture systems.

Table 2. Characteristics of commercially available 3D culture systems.

Table 3. Characteristics of microfluidic vasculature generation technologies.

Table 4. Principle, advantages and disadvantages of two vasculature generation strategies.

Supplemental material

Supplementary Material For: Research survey on microfluidics-based 3D culture systems

Download MS Word (19.2 KB)

Supplementary Material For: Supplementary Figure 1

Download MS Word (249.9 KB)

Supplementary Material For: Supplementary Figure 2

Download MS Word (84.1 KB)